247 related articles for article (PubMed ID: 32122329)
21. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis.
Valeriani E; Squizzato A; Gallo A; Porreca E; Vincent JL; Iba T; Hagiwara A; Di Nisio M
J Thromb Haemost; 2020 Jul; 18(7):1618-1625. PubMed ID: 32237269
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological treatment of acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study of 88 patients.
Sakamoto S; Shimizu H; Isshiki T; Kurosaki A; Homma S
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):176-184. PubMed ID: 32476952
[TBL] [Abstract][Full Text] [Related]
23. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of recombinant human soluble thrombomodulin for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: a single arm, non-randomized prospective clinical trial.
Hayakawa S; Matsuzawa Y; Irie T; Rikitake H; Okada N; Suzuki Y
Multidiscip Respir Med; 2016; 11():38. PubMed ID: 27826444
[TBL] [Abstract][Full Text] [Related]
25. Body mass index and weight loss as risk factors for poor outcomes in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
He X; Ji J; Liu C; Luo Z; Tang J; Yan H; Guo L
Ann Med; 2024 Dec; 56(1):2311845. PubMed ID: 38301276
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Qiu M; Chen Y; Ye Q
Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
[TBL] [Abstract][Full Text] [Related]
27. Systematic review and meta-analysis of clinical significance of autoantibodies for idiopathic pulmonary fibrosis.
Kamiya H; Panlaqui OM
BMJ Open; 2019 May; 9(5):e027849. PubMed ID: 31147365
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
[TBL] [Abstract][Full Text] [Related]
29. A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease.
Kamiya H; Panlaqui OM
BMC Pulm Med; 2021 May; 21(1):150. PubMed ID: 33952218
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of Krebs von den Lungen-6 (KL-6) measurement in idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
Aloisio E; Braga F; Puricelli C; Panteghini M
Clin Chem Lab Med; 2021 Jul; 59(8):1400-1408. PubMed ID: 33831978
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human soluble thrombomodulin ameliorates cerebral ischemic injury through a high-mobility group box 1 inhibitory mechanism without hemorrhagic complications in mice.
Nakamura Y; Nakano T; Irie K; Sano K; Tanaka J; Yamashita Y; Satho T; Matsuo K; Fujioka M; Ishikura H; Mishima K
J Neurol Sci; 2016 Mar; 362():278-82. PubMed ID: 26944163
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats.
Tanaka J; Seki Y; Ishikura H; Tsubota M; Sekiguchi F; Yamaguchi K; Murai A; Umemura T; Kawabata A
Br J Pharmacol; 2013 Nov; 170(6):1233-41. PubMed ID: 24004409
[TBL] [Abstract][Full Text] [Related]
33. Enhanced effect of recombinant human soluble thrombomodulin by ultrasound irradiation in acute liver failure.
Hoshino K; Nakamura Y; Nakano T; Watanabe A; Sheng H; Tachibana K; Ishikura H
Sci Rep; 2020 Feb; 10(1):1742. PubMed ID: 32015385
[TBL] [Abstract][Full Text] [Related]
34. Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model.
Iba T; Nakarai E; Takayama T; Nakajima K; Sasaoka T; Ohno Y
Crit Care; 2009; 13(6):R203. PubMed ID: 20003418
[TBL] [Abstract][Full Text] [Related]
35. Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF.
Farrand E; Vittinghoff E; Ley B; Butte AJ; Collard HR
Respirology; 2020 Jun; 25(6):629-635. PubMed ID: 31846126
[TBL] [Abstract][Full Text] [Related]
36. Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation.
Richeldi L
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S181-5. PubMed ID: 26595737
[TBL] [Abstract][Full Text] [Related]
37. Acute exacerbation of idiopathic pulmonary fibrosis triggered by
Suzuki A; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Mori Y; Kondoh Y
Respir Med Case Rep; 2018; 23():103-106. PubMed ID: 29719792
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of traditional Chinese medicine in patients with acute exacerbation of idiopathic pulmonary fibrosis: study protocol for randomized, controlled, exploratory clinical trial.
Hailong Z; Jiansheng L; Wen G; Lu W; Dong Z; Limin Z; Miao Z; Weixian L
Trials; 2022 Feb; 23(1):103. PubMed ID: 35109889
[TBL] [Abstract][Full Text] [Related]
39. Drug Treatment of Idiopathic Pulmonary Fibrosis: Systematic Review and Network Meta-Analysis.
Canestaro WJ; Forrester SH; Raghu G; Ho L; Devine BE
Chest; 2016 Mar; 149(3):756-66. PubMed ID: 26836914
[TBL] [Abstract][Full Text] [Related]
40. Effective control of relapsing disseminated intravascular coagulation in a patient with decompensated liver cirrhosis by recombinant soluble thrombomodulin.
Hasebe T; Sawada K; Nakajima S; Maeda S; Abe M; Suzuki Y; Ohtake T; Hasebe C; Fujiya M; Kohgo Y
Intern Med; 2014; 53(1):29-33. PubMed ID: 24390524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
